The United Laboratories International Holdings Limited (HKG:3933)
8.20
-0.05 (-0.61%)
Sep 1, 2026, 4:08 PM HKT
HKG:3933 Revenue
The United Laboratories International Holdings had revenue of 5.69B CNY in the half year ending December 31, 2025, a decrease of -16.70%. This brings the company's revenue in the last twelve months to 11.86B, down -15.91% year-over-year. In the year 2025, The United Laboratories International Holdings had annual revenue of 13.21B, down -3.99%.
Revenue (ttm)
11.86B CNY
Revenue Growth
-15.91%
P/S Ratio
1.18
Revenue / Employee
658.77K CNY
Employees
18,000
Market Cap
16.17B HKD
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 13.21B | -548.31M | -3.99% |
| Dec 31, 2024 | 13.76B | 19.06M | 0.14% |
| Dec 31, 2023 | 13.74B | 2.41B | 21.22% |
| Dec 31, 2022 | 11.33B | 1.63B | 16.81% |
| Dec 31, 2021 | 9.70B | 930.95M | 10.61% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| China Resources Pharmaceutical Group | 314.21B |
| Grand Pharmaceutical Group | 12.48B |
| Simcere Pharmaceutical Group | 10.07B |
| China Medical System Holdings | 10.06B |
| Shandong Xinhua Pharmaceutical Company | 9.78B |
| Luye Pharma Group | 7.02B |
| Sunshine Lake Pharma | 5.36B |
| Consun Pharmaceutical Group | 4.19B |
The United Laboratories International Holdings News
- 5 months ago - The United Laboratories International Holdings Earnings release: H2 2025 - Filings
- 5 months ago - The United Laboratories International Holdings Slides: H2 2025 - Filings
- 5 months ago - The United Laboratories International Holdings Annual report: H2 2025 - Filings